tirzepatide gip/glp-1 20mg | 20-Vial Kit | 400mg Total Tirzepatide — Provider-Supervised GLP-1 /

NICE guidance recommends individualised treatment targets and regular review of all diabetes medications to ensure continued appropriateness and effectiveness

Tirzepatide, as a dual GIP/GLP-1 agonist, may produce slightly more pronounced effects because it typically produces greater weight loss (15% to 20% of body weight versus 10% to 15% for pure GLP-1 agonists) and more dramatic metabolic improvements

No some doctors be lying you have to find a better doctor Hi ladies, so glad to find this site

The two substances affect the same neurons in specific parts of the brain, and the researchers have been able to demonstrate that GLP-1 affects the bodys response to nicotine